אינקליסירן (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "אינקליסירן" in Hebrew language version.

refsWebsite

Global rank Hebrew rank

4^th place

18^th place

4clinicaltrials.gov

5,225^th place

3,089^th place

2^nd place

10^th place

3,984^th place

9,600^th place

1healthbroadcastingservice.com

low place

low place

low place

low place

68^th place

170^th place

447^th place

285^th place

1fiercebiotech.com

low place

low place

low place

4,670^th place

1themedicinescompany.com

low place

low place

clinicaltrials.gov

clinicaltrials.gov

classic.clinicaltrials.gov

מחקר קליני מזהה NCT03814187 עבור "Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C (ORION-8)", באתר ClinicalTrials.gov

doi.org

doi.org

Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, et al. (בינואר 2017). "A Highly Durable RNAi Therapeutic Inhibitor of PCSK9". The New England Journal of Medicine. 376 (1): 41–51. doi:10.1056/NEJMoa1609243. PMC 5778873. PMID 27959715. {{cite journal}}: (עזרה)
Santulli G, Jankauskas SS, Gambardella J (במאי 2021). "Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk". Eur Heart J Cardiovasc Pharmacother. 7 (3): e11–e12. doi:10.1093/ehjcvp/pvab014. PMID 33655296. {{cite journal}}: (עזרה)

dx.doi.org

R. Scott Wright, Kausik K. Ray, Frederick J. Raal, David G. Kallend, Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis, Journal of the American College of Cardiology 77, 2021-03-09, עמ' 1182–1193 doi: 10.1016/j.jacc.2020.12.058

europa.eu

ema.europa.eu

"Leqvio EPAR". European Medicines Agency. 13 באוקטובר 2020. נבדק ב-6 בינואר 2021. {{cite web}}: (עזרה)

fda.gov

Center for Drug Evaluation and Research, FDA approves add-on therapy to lower cholesterol among certain high-risk adults, FDA, 2021-12-27

fiercebiotech.com

Taylor NP (26 באוגוסט 2019). "Medicines Company's PCSK9 drug hits phase 3 efficacy goals". FierceBiotech. {{cite web}}: (עזרה)

healthbroadcastingservice.com

"Novartis signs deal with Britain's NHS for new cholesterol drug Leqvio". Reuters. 2021-09-01.

nih.gov

pubmed.ncbi.nlm.nih.gov

Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, et al. (בינואר 2017). "A Highly Durable RNAi Therapeutic Inhibitor of PCSK9". The New England Journal of Medicine. 376 (1): 41–51. doi:10.1056/NEJMoa1609243. PMC 5778873. PMID 27959715. {{cite journal}}: (עזרה)
Santulli G, Jankauskas SS, Gambardella J (במאי 2021). "Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk". Eur Heart J Cardiovasc Pharmacother. 7 (3): e11–e12. doi:10.1093/ehjcvp/pvab014. PMID 33655296. {{cite journal}}: (עזרה)
R. Scott Wright, Kausik K. Ray, Frederick J. Raal, David G. Kallend, Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis, Journal of the American College of Cardiology 77, 2021-03-09, עמ' 1182–1193 doi: 10.1016/j.jacc.2020.12.058

ncbi.nlm.nih.gov

Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, et al. (בינואר 2017). "A Highly Durable RNAi Therapeutic Inhibitor of PCSK9". The New England Journal of Medicine. 376 (1): 41–51. doi:10.1056/NEJMoa1609243. PMC 5778873. PMID 27959715. {{cite journal}}: (עזרה)

novartis.com

"Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran" (הודעה לעיתונות). 6 בינואר 2020. נבדק ב-24 בדצמבר 2021. {{cite press release}}: (עזרה)

novartis.us

"FDA approves Novartis Leqvio (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year" (הודעה לעיתונות). 22 בדצמבר 2021. נבדק ב-24 בדצמבר 2021. {{cite press release}}: (עזרה)

tga.gov.au

Australian Government Department of Health Therapeutic Goods Administration, Leqvio, Therapeutic Goods Administration (TGA), ‏2021-09-22 (באנגלית)

themedicinescompany.com

"The Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of Inclisiran". The Medicines Company. נבדק ב-29 באוגוסט 2019. {{cite web}}: (עזרה)